NFKB1 and COVID-19: Finally, we employed a structure-based molecular docking method to demonstrate that the andrographolide could bind with TNF and NFkB1, potentially blocking the TNF-mediated NFkB1 pathway underpinning cytokine storm in severe patients with COVID-19.